Virtual medical education event on

PARP inhibitors in prostate cancer:

Practical considerations for clinical practice

Dr. Joaquin Mateo

Group Leader, Prostate Cancer Translational Research Group
Institute of Oncology Vall d’Hebron University Hospital,
Barcelona, Spain

Dr. Avivit Peer

Head of clinical trial unit, Head of Genitourinary clinic, Oncology institute
Rambam Health care Campus. Haifa, Israel

Prof. Dov Hershkovitz

Director - Institute of Pathology
Tel-Aviv Medical Sourasky Center, Israel

Dr. Meital Levartovsky

Senior oncologist, GU unit, Department of oncology
Sheba Medical Center, Israel

Tuesday, 30 November 2021

19:00-20:30

Live “Open Mic” webcast through “TEAMS” platform

AGENDA

19:00 – 19:05 Welcome and introduction
Moderator - Dr. Avivit Peer
Optimizing outcomes for mCRPC patients
19:05 – 19:30 The emerging role of PARP inhibitors in prostate cancer
Dr. Joaquin Mateo
BRCA 1, BRCA 2 and ATM -Testing Journey
19:30 – 19:45 The pathologist perception on real life implementation of molecular testing and tissue sampling in prostate cancer
Prof. Dov Hershkovitz
From international guidelines into clinical practice - The oncologist perspective
19:45 - 20:05 Management of patients with mCRPC harbouring BRCA alterations – case studies presentation
Dr. Meital Levartovsky
20:05 – 20:30 Therapeutic implications of PARPi treatment in the mCRPC clinical landscape
All

First Name

Last Name

Telephone

Email

job

I agree to receive promotional material from MSD via emails, text messages (SMS) and/or other communication channels. I agree that my information will be stored in MSD’s customers’ database and be used for the purposes defined in the privacy notice. Please note that the information is provided to MSD of your own free will and that you are not legally obligated to provide such information. The information about you will be stored in the MSD databases and will be used by MSD to maintain contact with you, to provide additional services in the future, and to contact you regarding issues related to your area of expertise and to MSD, its products and relevant events, while complying with the law and the ethical rules. The information may be transferred to companies related to MSD and to its suppliers in Israel and abroad for the same purposes and will be treated while protecting your privacy according to MSD standards. If you wish to update the information or to be deleted from our database, you may contact us at any time at POC-ISRAEL@merck.com.

I declare that I am a healthcare professional.